HEALTHFINANCIAL TIMES WORLD
US start-up wins EU approval for sight-restoring bionic eye
A US start-up named Science Corp has received EU approval for a bionic eye designed to restore sight. This approval will enable the company to begin treating patients with retina implants within the coming months.
Related Signal
Adjacent reporting
- STAT+: ‘Cochlear implant for blindness’ debuts in Europe, could launch in U.S. in 2027
- STAT+: Ophthalmology venture grabs investors’ attention, raises $330 million
- Final frontier for meds? UK startup sends drug-making into space
- STAT+: AI company Anthropic announces it will begin developing drugs of its own